$1.75
0.05[2.94%]
At close: Apr 26
$1.75
0[0.00%]
After Hours: 7:56PM EDT
Xeris Biopharma Holdings
(NASDAQ:XERS)Xeris Biopharma Holdings Stock (NASDAQ:XERS), Insider Trading Activity
Xeris Biopharma Holdings: Insider buying and selling updated today.
Shares Outstanding
148.254M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | John Schmid | DIRECTOR | 4.5K | $2.16 | $9.72K | BUY | 6.46% | 74.159K | Mar 14 | View |
| Nov 29, 2023 | JEFFREY SHERMAN | DIRECTOR | 5.4K | $1.87 | $10.10K | BUY | 5.01% | 113.278K | Nov 27 | View |
| Nov 21, 2023 | DAWN HALKUFF | DIRECTOR | 5.41K | $1.84 | $9.95K | BUY | 9.41% | 62.91K | Nov 20 | View |
| Nov 21, 2023 | Steven Pieper | SEE REMARKS | 28K | $1.95 | $54.60K | BUY | 2.44% | 1.176912M | Nov 20 | View |
| Nov 17, 2023 | John Schmid | DIRECTOR | 6.5K | $1.51 | $9.81K | BUY | 10.29% | 69.659K | Nov 16 | View |
| Nov 17, 2023 | Patrick John Shannon Jr | SEE REMARKS | 30.769K | $1.64 | $50.40K | BUY | 2.23% | 1.408575M | Nov 17 | View |
| Nov 15, 2023 | MARLA PERSKY | DIRECTOR | 6.37K | $1.58 | $10.06K | BUY | 11.08% | 63.87K | Nov 14 | View |
| Aug 09, 2023 | Paul Edick | SEE REMARKS | 10K | $2.38 | $23.79K | BUY | 0.43% | 2.321494M | Aug 09 | View |
| Dec 14, 2022 | Paul Edick | SEE REMARKS | 20K | $1.45 | $29.00K | BUY | 1.30% | 1.561494M | Dec 13 | View |
| May 13, 2022 | Paul Edick | SEE REMARKS | 100K | $1.40 | $140.38K | BUY | 6.94% | 1.541494M | May 12 | View |
| Feb 24, 2022 | STEVEN PRESTRELSKI | CHIEF SCIENTIFIC OFFICER | 0 | $1.55 | -$19.41K | SELL-OPTIONS | 0.00% | 569.78K | Feb 22 | View |
| Nov 16, 2021 | Paul Edick | SEE REMARKS | 20K | $2.28 | $45.66K | BUY | 2.43% | 841.494K | Nov 15 | View |
| Nov 12, 2021 | Patrick John Shannon Jr | SEE REMARKS | 100K | $2.10 | $209.50K | BUY | 37.90% | 363.829K | Nov 11 - Nov 12 | View |
| Nov 12, 2021 | Paul Edick | SEE REMARKS | 200K | $2.08 | $415.76K | BUY | 32.18% | 821.494K | Nov 11 | View |
| Nov 12, 2021 | Steven Pieper | SEE REMARKS | 25K | $2.00 | $49.92K | BUY | 15.81% | 183.108K | Nov 10 | View |
| Apr 13, 2021 | STEVEN PRESTRELSKI | CHIEF SCIENTIFIC OFFICER | -10K | $4.07 | -$40.73K | SELL | -1.97% | 496.824K | Apr 12 | View |
| Jan 15, 2021 | STEVEN PRESTRELSKI | CHIEF SCIENTIFIC OFFICER | -10K | $6.01 | -$60.06K | SELL | -2.40% | 406.824K | Jan 13 | View |
| Jan 12, 2021 | STEVEN PRESTRELSKI | CHIEF SCIENTIFIC OFFICER | -10K | $5.72 | -$57.24K | SELL | -2.34% | 416.824K | Jan 11 | View |
| Dec 10, 2020 | Paul Edick | 10K | $4.06 | $40.55K | PURCHASE | 2.41% | 424.564K | Dec 09 | View | |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.